Other
Acesion Pharma
is a Denmark-based biotechnology company that researches and develops small-molecule drugs for the treatment of atrial fibrillation... Read moreAcesion Pharma
is a Denmark-based biotechnology company that researches and develops small-molecule drugs for the treatment of atrial fibrillation... Read moreNews
Jan 07, 2026
Clinical Trials Arena
Acesion Pharma: Acesion begins patient enrolment in AP31969 Phase II AF study
Jan 06, 2026
PharmaTimes
Acesion Pharma: Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
Dec 13, 2023
FinanzNachrichten
Acesion Pharma: Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
May 16, 2023
Pharmabiz
Acesion Pharma: Acesion Pharma reports positive preclinical data for AP31969 for chronic oral maintenance treatment to prevent AF recurrence
May 15, 2023
Outsourcing-Pharma
Acesion Pharma: Drug to treat atrial fibrillation without safety issues being developed by Acesion Pharma
Mar 19, 2023
Outsourcing-Pharma
Acesion Pharma: Acesion's positive trial data for treatment of atrial fibrillation
Mar 14, 2023
Endpoints News
Acesion Pharma: Denmark-based biotech releases PhII data on AF treatment
May 06, 2020
The Pharma Letter
Acesion Pharma: BRIEF-Key appointments at Denmark's Acesion Pharma
Nov 09, 2018
Pharmabiz
Acesion Pharma: Acesion reports positive results from phase 1 trial of AP30663 to treat atrial fibrillation
Nov 05, 2018
FinanzNachrichten
Acesion Pharma: Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Acesion Pharma Competitors
1
2
3
4
5
6
7
8
9
10